Safety and pharmacokinetics of anti‐TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial
Authors
Pratima Chowdary,
Stefan LethagenUte Friedrich,
B. Brand,
C. Hay,
F. Karim,
Robert Klamroth,
Paul Knoebl,
Michael Laffan,
Johnny Mahlangu,
Wolfgang Miesbach,
Jørn Nielsen,
Mónica Martín‐Salces,
Pantep Angchaisuksiri +12 authors
,
Paul Knöbl Tip Tip